Since providing the world’s first injection system more than 90 years ago, we have been committed to making diabetes drug delivery as simple as possible.
At Novo Nordisk, we strive to understand the everyday needs of people with diabetes with the aim of developing injection pens and needles that ease the burden, and meet the diverse needs, of millions of people living with the disease。 We do this by combining patient insight with engineering excellence to design our injection pens and needles。
This allows us to make a broad range of innovative, durable and prefilled insulin and GLP-1 pens and needles for diabetes treatments that meet your needs*. As a company, we are committed to improving the lives of people living with diabetes by continuing to ease the burden of diabetes through innovative injection pens and needles.
*Our full range may not be available in your country. Please ask your doctor or nurse if you have any questions
Like this? You may also be interested in:
HQ19DN00010。 March 2019。